American Century Focused Intl Gr A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
American Century Focused International Growth Fund A Class AFCLX
- NAV / 1-Day Return 18.84 / −0.42 %
- Total Assets 194.1M
-
Adj. Expense Ratio
1.350%
- Expense Ratio 1.350%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 90%
USD | NAV as of Aug 15, 2026 | 1-Day Return as of Aug 15, 2026, 12:07 AM GMT+0
Morningstar’s Analysis AFCLX
Will AFCLX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 36.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 7.87 | 16M | Technology |
Samsung Electronics Co Ltd | 4.92 | 10M | Technology |
ASML Holding NV | 4.26 | 9M | Technology |
Societe Generale SA | 3.23 | 7M | Financial Services |
AstraZeneca PLC | 3.16 | 7M | Healthcare |
Iberdrola SA | 2.75 | 6M | Utilities |
Schneider Electric SE | 2.62 | 5M | Industrials |
Galderma Group Ag Common Stock Chf.01 | 2.55 | 5M | — |
Novonesis (Novozymes) B Class B | 2.54 | 5M | Basic Materials |
Terumo Corp | 2.36 | 5M | Healthcare |